Delivery Order SPE2DB22D3401-SPE2DB26FT0KB
Award Date 10/30/25
Potential Completion Date 10/31/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,669.17 to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Rexulti (brexpiprazole) 0.5 mg tablets in a 30-count package. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $5,720.78 to AmerisourceBergen Drug Corp for the supply of Rexulti (brexpiprazole) 2 mg tablets in a quantity of 30 units. This firm fixed price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, was competitively awarded with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,322.33 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Rexulti (brexpiprazole) 1 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,195.59 by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Rexulti 2 mg tablets (30-count packages). The contract carries a firm fixed price structure with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by September 10, 2025, with performance conducted from the vendor's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $59,725.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count units), with an ultimate completion date of June 2, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999.99 million and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $11,846.76 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed price contract. The award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery order and functions as a...
- The Defense Logistics Agency awarded a delivery order valued at $46,854.75 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and represents a non-competitive set-aside delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,896.99 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on October 27, 2025, with an ultimate completion date of October 28, 2025, and represents a non-competitive set-aside delivery against an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Rexulti 0.5 mg tablets (30-count packages) valued at $14,929.95 with a firm fixed price structure. This delivery order represents a competitive award with no set-aside designation and is set to conclude by August 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work from its Corporate Office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,239.25 by the Defense Logistics Agency on October 24, 2025, for the supply of Rexulti 3 mg tablets (30-count packaging). This firm fixed-price, competitively awarded delivery order is scheduled for completion by October 27, 2025, with performance taking place at the company's Conshohocken facility. The award represents a child contract under...